In addition, 49.5% (54/109) patients with low SFRP1 level correlated with advanced tumor stage (P = 0.007, Table 1) and lymph node metastasis (P = 0.010, Table 1). This evidence concerns the gene SFRP1 and metastatic malignant neoplasm in the lymph nodes.